Physician profile
Graham Abra
NPI 1760644678
$18,169.41
in general payments reported to CMS, 2019-2025
9 companies · $99.59 in 2025
The $99.59 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.81 · 2020: $4,000 · 2021: $2,040 · 2022: $2,371 · 2023: $4,019 · 2024: $5,602 · 2025: $99.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,998 · Travel and Lodging: $1,273 · Food and Beverage: $996 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $450 · Education: $3.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,997.50 |
| Travel and Lodging | $1,273.31 |
| Food and Beverage | $996.38 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $450.00 |
| Education | $3.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akebia Therapeutics INC | $6,040.00 | 2020-2021 | |
| Fresenius USA Marketing, INC. | $5,263.87 | 2024 | |
| Baxter Healthcare | $4,244.14 | 2022-2023 | Renal - Pd |
| Outset Medical INC | $2,023.68 | 2022-2023 | |
| Nxstage Medical, INC. | $411.66 | 2023-2025 | Liberty Select Cycler, Nxstage System One, Pureflow Sl |
| Otsuka America Pharmaceutical, INC. | $145.17 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $19.89 | 2019 | |
| Amgen INC. | $17.92 | 2019 | |
| Travere Therapeutics, INC. | $3.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Graham Abra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.